Intensity of observation with active surveillance or watchful waiting in men with prostate cancer in the United States
Bashir Al Hussein Al Awamlh(Cornell University), Jonathan E. Shoag(University Hospitals of Cleveland), Woodson Smelser(Washington University in St. Louis), Patrick Lewicki(NewYork–Presbyterian Hospital), Kelvin A. Moses(Bristol-Myers Squibb (Germany)), Camilo Arenas‐Gallo(University Hospitals of Cleveland), Daniel A. Barocas(Vanderbilt University Medical Center), Spyridon P. Basourakos(Mayo Clinic in Arizona), Xian Wu(East Carolina University), Richard M. Hoffman(University of Iowa)
Cited by 11
Related Papers
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
|The Journal of Urology|2012|487